Fixderma is a Gurugram-based cosmeceutical skincare company selling dermatologist-recommended products through clinics, pharmacies, online and exports, with Lotus Herbals as a minority investor.

This Startup Deep Dive explains what Fixderma does, how it makes money, who backs it, how it compares with rivals and what could go wrong, using publicly available information. It is educational and not investment advice. Last updated: October 2026.

Fixderma in Brief

• What it is: Fixderma is an Indian Dermatologist-led skincare (cosmeceuticals) company based in Gurugram.
• Who it serves: online shoppers, retail customers, marketplaces and distribution partners.
• Sells dermatologist-recommended cosmeceutical skincare, about 150 products and 175 formulations
• Premium sister line Fixderma Cosmetic Laboratories launched in 2017, priced from Rs 1,200 versus Rs 400 for the main line
• Launched babycare line Hoopoe with seven products in early 2025
• Funding: Rs 38 crore from Lotus Herbals in 2021 (reported).

Fixderma Quick Facts

Figures marked “reported” come from published reports and may differ between sources; “Not disclosed” means no reliable public figure was found.

What Is Fixderma?

Fixderma operates in the Dermatologist-led skincare (cosmeceuticals) space in India. Understanding a company like this starts with three questions: who is the customer, what painful problem is being solved, and why the solution is better than the alternatives. The sections below apply that lens to Fixderma.

• Sells dermatologist-recommended cosmeceutical skincare, about 150 products and 175 formulations
• Premium sister line Fixderma Cosmetic Laboratories launched in 2017, priced from Rs 1,200 versus Rs 400 for the main line
• Launched babycare line Hoopoe with seven products in early 2025
• Works with more than 15,000 dermatologists and is in over 25,000 stores in India
• Exports to over 35 countries

The Origin Story of Fixderma

Every company starts from a noticed gap and a team willing to commit to closing it. Strong origin stories are specific: a clear problem, a founding team with relevant skills, and an early product that real customers could test. Founder-market fit, meaning the team’s lived experience or technical depth in the domain, tends to predict how fast a young company learns.

• Founders: Shaily Mehrotra, Anurag Mehrotra.
• Founded in Gurugram, described in recent coverage as debuting in 2010 as a dermatologist-focused business, though other sources say 2006 or 2008
• Shaily Mehrotra is founder and CEO; Anurag Mehrotra is co-founder and chairman
• Started with three people and expanded to Southeast Asia in its first year
• Own factory set up around 2011-12

Key Milestones and Challenges

No startup grows in a straight line. Early years usually involve slow adoption, product rewrites, hiring mistakes and funding gaps. In the Dermatologist-led skincare (cosmeceuticals) sector the common turning points are a first paying customer, a regulatory approval, a successful product demonstration or a funding round that lets the team invest ahead of demand. How a team responds to setbacks says more about resilience than any single headline.

• 2010: Debuted as a dermatologist-focused brand (per recent coverage)
• 2011-12: Own factory set up; manufacturing in Nimrana, Rajasthan
• 2017: Premium sister brand Fixderma Cosmetic Laboratories launched
• 2020: Entered D2C and OTC
• Nov 2021: Lotus Herbals invested Rs 38 crore for a 30-32 percent stake (reports vary on stake)
• Jul 2024: First exclusive store opened in Gurugram
• Feb 2025: Babycare line Hoopoe announced
• 2025: Sales up 30 percent; Shark on Shark Tank India Season 5 for founder Shaily Mehrotra

Fixderma Funding and Investors

Funding history shows how much outside confidence a company has attracted and how long it can operate before needing more capital. Figures below are reported and may differ between sources; valuation figures are estimates unless the company has confirmed them.

• Nov 2021: Lotus Herbals corporate minority investment, reported Rs 38 crore for a 30-32 percent stake
• No later rounds found

How Does Fixderma Make Money? (Business Model)

A business model describes who pays, how often and how much it costs to serve them. Strong models show repeat usage, improving margins with scale and acquisition channels that do not depend only on paid spend. Weak models show one-off sales, rising costs and growth that stops when spending stops. For companies selling to online shoppers, retail customers, marketplaces and distribution partners, sales cycles and contract size matter as much as headline growth.

• Four verticals: OTC, dermatologist, e-commerce and exports
• Revenue mix reports differ: online about 35-40 percent, dermatologists about 25-30 percent, exports about 20-25 percent, OTC up to 15 percent or 5 percent
• In-house manufacturing at Nimrana, Rajasthan
• Plans at least 10 exclusive stores by end of 2025

The Numbers: Fixderma Financials

Financial figures show whether growth is turning into a self-sustaining business. Small and private companies often disclose little, so any number below is included only if it was found in public reporting.

• FY25: sales growth about 30 percent; FY26 target 55 percent (other coverage cites 30-40 percent)
• Absolute revenue and profit not found in sources read
• Long-term ambition: Rs 1,000 crore brand
• About 700 employees

Market Opportunity for Fixderma

Market size is easy to exaggerate, so a useful approach separates the total market from the portion a company can realistically reach with its current product and distribution. The main forces behind demand in this sector are rising internet and smartphone use, growing online retail, digital payments, quick commerce and a younger consumer base that is open to new brands. Each of these widens the opportunity, but capital efficiency and execution decide who captures it.

• Indian derma-cosmetics and skincare with D2C and clinic channels
• Over 10,000 D2C brands competing, per one report

Technology and Product at Fixderma

Technology is rarely the whole moat, but it drives speed, cost and customer experience. A practical way to assess it is to separate the capability the company controls from the commodity infrastructure it rents. In this sector the important factors are supply-chain reliability, brand trust, product quality, data on customer behaviour and the efficiency of fulfilment.

• Holds two patents with two more reportedly in progress
• 175 formulations made in-house

Team and Culture at Fixderma

Teams are the most important and least measurable asset of a young company. Look at how complementary the founders’ skills are, how deep the second layer of leadership is, and how the company hires and retains specialists. Culture shows up in small repeated behaviours: how quickly bad news travels upward and whether commitments to customers are kept.

• Shaily Mehrotra, founder and CEO
• Anurag Mehrotra, co-founder and chairman
• Preetam Jena, CMO and eCommerce head
• About 700 employees

Fixderma Competitors: Competitive Landscape

A fair competitive analysis names direct rivals, adjacent players who could move into the space, and the customer’s default alternative. Durable advantages include proprietary data or technology, licences and approvals, brand trust, switching costs and cost leadership.

Risks and Challenges for Fixderma

• Dependence on dermatologist and export channels
• Intense D2C competition
• Absolute financials undisclosed
• Offline store expansion adds cost
• Competition: low barriers to entry and large marketplaces make it hard for a brand to stay differentiated.
• Customer acquisition cost: paid marketing can become expensive and erode margins as a brand scales.

Risk is not a reason to avoid a company; it is a reason to price it correctly and to monitor the right indicators over time. Regulation in this sector is shaped by consumer protection rules, FSSAI and BIS standards where relevant, the Legal Metrology rules and e-commerce regulations.

Fixderma Growth Outlook: What to Watch

• Targets 30-55 percent growth
• Plans to double store presence, expand exports and relaunch men's skincare
• Key indicators: repeat purchase rate, average order value, gross margin, contribution margin and customer acquisition cost.
• Funding position: Whether Fixderma can reach its next milestone before needing new capital.
• Regulation: Changes from consumer protection rules, FSSAI and BIS standards where relevant, the Legal Metrology rules and e-commerce regulations.

Industry Context: Where Fixderma Fits

India's consumer market is large, young and increasingly online. Rising smartphone and internet use, digital payments and faster delivery have helped direct-to-consumer brands, marketplaces and quick-commerce platforms reach customers who once relied on local shops. Established companies, marketplaces and new brands now compete for the same shoppers.

Success in consumer businesses usually depends on a clear brand promise, repeat customers and healthy unit economics, not on sales volume alone. Companies that control quality, understand customer needs and manage marketing costs tend to build more durable brands than those that grow mainly by discounting.

For readers new to this field, a useful habit is to separate announcements from evidence. A plan, a partnership or a funding headline describes intent, while a delivered product, a paying customer or an audited financial statement describes results. Comparing the two over time shows how reliably a company turns promises into outcomes.

Bull Case and Bear Case for Fixderma

An investment thesis is a short, testable statement of why a company could become far more valuable, together with what evidence would prove it wrong. The points below are general to this sector and are not forecasts for Fixderma.

Bull case

• A growing base of online shoppers expands the potential market.
• Strong brands can earn repeat purchases and pricing power.
• Distribution through marketplaces, quick commerce and stores widens reach.

Bear case

• Heavy competition and discounting can hurt margins.
• Rising marketing costs can slow profitable growth.
• Supply-chain or quality problems can quickly damage trust.

Lessons Founders and Investors Can Take from Fixderma

Studying a company in the Dermatologist-led skincare (cosmeceuticals) space offers lessons that go beyond any single firm. The points below are general lessons for the sector and are not claims about Fixderma.

• A clear brand identity and consistent product quality matter more than short-term sales spikes.
• Repeat customers lower acquisition costs and make growth more profitable.
• Controlling the supply chain helps protect quality and margins as volumes grow.
• Selling across several channels, such as own website, marketplaces, quick commerce and stores, reduces dependence on one platform.
• Healthy contribution margins are a better sign of progress than revenue growth alone.

How to Evaluate Fixderma as a Startup

• Customer clarity: Can Fixderma name its customer and the problem it solves in one sentence?
• Evidence of demand: Look for repeat customers, signed contracts or measurable usage rather than announcements alone.
• Economics: Check whether margins improve as volume grows.
• Execution: Compare announced timelines with what has actually been delivered.
• Funding runway: Estimate how long current capital lasts at the present spending rate.
• Regulatory standing: Confirm required approvals are in place.
• Customer concentration: Check whether a few customers account for most of the revenue.
• Management depth: Look for experienced leaders beyond the founders and a stable core team.

The Takeaway

Fixderma is part of India’s growing Dermatologist-led skincare (cosmeceuticals) ecosystem. The useful lesson from studying it is the discipline of asking structured questions about customers, economics, advantage and resilience. Companies that answer them well, repeatedly and under pressure are the ones that endure. Readers should treat any single report, ranking or funding headline as one input among many, and should re-check key facts against recent company announcements. Because public information on young companies is often limited, patience in verifying claims is part of good analysis. Public sources can also describe the same company in different ways, so it is worth checking dates, definitions and whether a figure refers to revenue, total income or transaction value, and whether it covers one entity or a wider group, before drawing conclusions. Small differences in rounding, currency conversion or reporting periods can also change how a figure reads. Comparing the same figure across several recent reports helps show whether it is stable or has changed over time. This article is educational and is not investment advice.

• Clear customers and repeat demand matter more than announcements.
• Regulation and capital needs shape how fast a startup in this sector can grow.
• Track a few leading indicators over time rather than one headline metric.

Fixderma FAQs: Frequently Asked Questions

What is Fixderma?

Fixderma is a Gurugram-based cosmeceutical skincare company selling dermatologist-recommended products through clinics, pharmacies, online and exports, with Lotus Herbals as a minority investor. It is profiled in the Startup Deep Dive series, which explains business model, funding, competitors and risks.

Who founded Fixderma?

Fixderma was founded by Shaily Mehrotra, Anurag Mehrotra, and the company reports a founding year of reports differ: 2006, 2008 or 2010 (recent articles say 2010).

How much funding has Fixderma raised?

Rs 38 crore from Lotus Herbals in 2021 (reported). Funding figures are reported and may differ between sources, so readers should check the latest company announcements.

How does Fixderma make money?

Fixderma earns revenue from its Dermatologist-led skincare (cosmeceuticals) products and services sold to online shoppers, retail customers, marketplaces and distribution partners. The exact revenue mix is described in the business model section and is not fully disclosed publicly.

Who are the competitors of Fixderma?

Reported rivals include Dot & Key, Dr Sheth's, The Derma Co, Minimalist. See the competitor comparison above for how they differ.

What are the main risks for Fixderma?

Main risks include competition: low barriers to entry and large marketplaces make it hard for a brand to stay differentiated, funding and capital needs, competition and regulation by consumer protection rules, FSSAI and BIS standards where relevant, the Legal Metrology rules and e-commerce regulations. This is educational content, not investment advice.

Related Startup Deep Dives: Lucid Diagnostics — short profile of what is publicly known | TeamIndus — India’s private Moon-race team that lost its launch deal. Browse the full Startup Deep Dive series.

Source

Source: Publicly available data, published reports, industry research, and other credible sources.